Active Ingredient (Generic Name) | Recombinant Human Erythropoietin Alfa (4000IU) |
---|---|
Manufacturer | Roche Pharma |
Packaging | 6 Syringe (0.3ml each) |
Strength | 4000IU |
Delivery Time | 8 Days |
Neorecormon 4000 IU contains Epoetin Alfa, a recombinant human erythropoietin that is used to treat anemia, particularly in patients with chronic kidney disease (CKD) or those undergoing chemotherapy. Epoetin Alfa stimulates the production of red blood cells (RBCs) by the bone marrow, mimicking the action of the naturally occurring hormone erythropoietin.
Neorecormon is a biosimilar to erythropoietin, and is often used in patients who are unable to produce enough erythropoietin on their own due to kidney disease or chemotherapy-related suppression of RBC production. The 4000 IU dose of Neorecormon helps to raise and maintain red blood cell counts, improving symptoms of anemia, such as fatigue, weakness, and shortness of breath.
✅ Chronic Kidney Disease (CKD) Anemia — For anemia due to CKD in both hemodialysis and non-dialysis-dependent patients.
✅ Chemotherapy-Induced Anemia — For patients undergoing chemotherapy for cancer who develop anemia.
✅ Anemia in HIV-infected Patients — To treat anemia caused by the use of certain medications in HIV-positive individuals.
✅ Surgical Blood Management — To reduce the need for blood transfusions during certain surgeries.
Increases RBC production: Stimulates erythropoiesis (red blood cell production) in the bone marrow.
Improves symptoms of anemia: Reduces fatigue, weakness, and dizziness associated with low RBC count.
Reduces need for blood transfusions: Helps maintain adequate hemoglobin levels without transfusions.
Convenient dosing: Available in various formulations, with Neorecormon 4000 IU being one of the commonly used doses for effective treatment.
Epoetin Alfa, the active ingredient in Neorecormon, is a synthetic version of the naturally occurring erythropoietin. Erythropoietin is a hormone primarily produced by the kidneys that stimulates the production of red blood cells in the bone marrow. In patients with anemia, particularly those with kidney disease or undergoing chemotherapy, Epoetin Alfa helps increase RBC production, thus improving hemoglobin levels and oxygen transport in the blood.
Neorecormon 4000 IU contains Epoetin Alfa, a recombinant human erythropoietin that is used to treat anemia, particularly in patients with chronic kidney disease (CKD) or those undergoing chemotherapy. Epoetin Alfa stimulates the production of red blood cells (RBCs) by the bone marrow, mimicking the action of the naturally occurring hormone erythropoietin.
Neorecormon is a biosimilar to erythropoietin, and is often used in patients who are unable to produce enough erythropoietin on their own due to kidney disease or chemotherapy-related suppression of RBC production. The 4000 IU dose of Neorecormon helps to raise and maintain red blood cell counts, improving symptoms of anemia, such as fatigue, weakness, and shortness of breath.
✅ Chronic Kidney Disease (CKD) Anemia — For anemia due to CKD in both hemodialysis and non-dialysis-dependent patients.
✅ Chemotherapy-Induced Anemia — For patients undergoing chemotherapy for cancer who develop anemia.
✅ Anemia in HIV-infected Patients — To treat anemia caused by the use of certain medications in HIV-positive individuals.
✅ Surgical Blood Management — To reduce the need for blood transfusions during certain surgeries.
Increases RBC production: Stimulates erythropoiesis (red blood cell production) in the bone marrow.
Improves symptoms of anemia: Reduces fatigue, weakness, and dizziness associated with low RBC count.
Reduces need for blood transfusions: Helps maintain adequate hemoglobin levels without transfusions.
Convenient dosing: Available in various formulations, with Neorecormon 4000 IU being one of the commonly used doses for effective treatment.
Epoetin Alfa, the active ingredient in Neorecormon, is a synthetic version of the naturally occurring erythropoietin. Erythropoietin is a hormone primarily produced by the kidneys that stimulates the production of red blood cells in the bone marrow. In patients with anemia, particularly those with kidney disease or undergoing chemotherapy, Epoetin Alfa helps increase RBC production, thus improving hemoglobin levels and oxygen transport in the blood.